References
- Marshall-Clarke S, Reen D, Tasker L, Hassan J. Neonatal immunity: How well has it grown up?. Immunol Today 2000; 21: 35–41
- Ddurandy A, DeSaint-Basile G, Lisouska-Grospierre B, et al. Undetectable CD40 ligand expression on T-cells and low B-cell responses to CD40 binding agonists in human newborns. J Immunol 1995; 154: 1560–1568
- Lewis DB, Yu CC, Meyer J, et al. Cellular and molecular mechanisms for reduced interlukin-4 and interferon-γ production by neonatal T-cells. J Clin Invest 1991; 87: 194–202
- Muthukkumar S, Goldstein J, Stein KE. Ability of B cells and dendritic cells to present antigen increases with ontogeny. J Immunol 2000; 165: 4803–4813
- Taylor S, Bryson YJ. Impaired production of γ-interferon by newborn cells in vitro is due to functionally immature macrophages. J Immunol 2000; 165: 1493–1497
- Adkins B, Du RQ. Newborn mice develop Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J Immunol 1998; 160: 4217–4224
- Adkins B, Ghanei A, Hamilton K. Development regulation of IL-4, IL-2 and IFN-γ production by murine peripheral T lymphocytes. J Immunol 1993; 151: 6617–6626
- Dadaglio G, Sun CM, Lo-Man R, Siegrist CA, Ledlerc C. Efficient in vivo priming of specific cytotoxic T-cell responses by neonatal dendritic cells. J Immunol 2002; 168: 2219–2224
- Forsthuber T, Yip HC, Lehmann PV. Induction of Th1 and Th2 immunity in neonatal mice. Science 1996; 271: 1728–1730
- Brass C, Stevens DA. Maturity as a critical determinant of resistance to fungal infections: studies in murine blastomycosis. Infect Immun 1982; 36: 387–395
- Brummer E, Restrepo A, Stevens D, Azzi R, Gomez AM, Hoyos GL, et al. A murine model of paracoccidioidomycosis: Production of acute pulmonary or chronic pulmonary disseminated disease using young mice, immunological and pathological observations. J Exp Pathol 1984; 1: 241–255
- Corbel MJ, Eades SM. Examination of the effect of age and acquired immunity on susceptibility of mice to infection with Aspergillus fumigatus. Mycopathologia 1977; 60: 70–85
- Brummer E, Morozumi PA, Vo PT, Stevens DA. Protection against pulmonary blastomycosis. II. Adoptive transfer with T-lymphocytes, but not serum, from mice rendered resistant by resolution of a subcutaneous non-lethal infection. Cell Immunol 1982; 73: 349–357
- Harvey RP, Schmid ES, Carrington CC, Stevens DA. Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. Am Rev Respir Dis 1978; 117: 695–703
- Morozumi PA, Halpern JW, Stevens DA. Susceptibility differences of inbred strains of mice to blastomycosis. Infect Immun 1981; 32: 160–168
- Ganer A, Brummer E, Stevens DA. Correlation of susceptibility of immature mice to fungal infection (blastomycosis) and effector cell function. Infect Immun 2000; 68: 6833–6839
- Brummer E, Hanson LH, Restrepo A, Stevens DA. In vivo and in vitro activation of pulmonary macrophages by IFN-γ for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. J Immunol 1988; 140: 2786–2789
- Sugar AM, Brummer E, Stevens DA. Murine pulmonary macrophages: Evaluation of lung lavage fluids, miniaturized monolayer, and candidacidal activity. Am Rev Respir Dis 1983; 127: 110–112
- Finkel-Jimenez B, Wuthrich M, Brandhorst TT, Klein B. Down regulation of phagocyte TNF-α production by WI-1 adhesin imparts pathogenicity of Blastomyces dermatitidis. J Immunol 2001; 166: 2665–2673
- Finkel-Jimenez B, Wuthrich M, Klein BS. BAD1, an essential virulence factor of Blastomyces dermatitidis suppresses host TNF-α production through TGF-β dependent and independent mechanisms. J Immunol 2002; 158: 5746–5755
- Bryson YJ, Winter HS, Gard SE, Fischer TJ, Stiehm ER. Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol 1980; 55: 191–200
- Wakasugi N, Virelizier JL, Arenzana-Seisdedos F, et al. Defective IFN-γ production in human neonates. II. Role of increased sensitivity to the suppressive effects of prostaglandin. Eur J Immunol 1985; 134: 172–176
- Wilson CB, Westall J, Johnson L, et al. Decreased production of interferon-γ by human neonatal cells: intrinsic and regulatory deficiencies. J Clin Invest 1986; 77: 860–865
- Wakasugi N, Virelizier JL. Defective IFN-γ production in human neonates. I. Disregulation rather than abnormality. J Immunol 1985; 134: 167–171
- White GP, Watt PM, Holt BJ, Holt PG. Differential patterns of methylation of the IFN-γ promoter at CpG and non-CpG sites underlie differences in IFN-γ gene expression between human neonatal and adult CD45Ro- T-cells. J Immunol 2002; 168: 2820–2827
- Brummer E, Sugar AM, Stevens DA. Enhanced oxidative burst in immunologically activated, but not elicited, polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun 1985; 49: 396–401
- Ambruso DR, Bentwood B, Henson PM, Johnston RB. Oxidative metabolism of cord blood neutrophils: Relationship to content and degranulation of cytoplasmic granules. Pediatric Res 1984; 18: 1148–1153
- Mills FL, Thompson T, Bjorksten B, Filipovich D, Quie PG. The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mother. Pediatrics 1979; 63: 429–434
- Xanthou M, Valassi-Adam E, Kintzonidou F. Phagocytosis and killing ability of Candida albicans by blood leukocytes of healthy term and preterm babies. Arch Dis Child 1975; 59: 72–75
- Huang D, Schwacha MG, Eisenstein TK. Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect Immun 1996; 64: 3786–3792
- Licinio J, Prolo P, McCann SM, Wong M. Brain iNOS:current understanding and clinical implications. Mol Med Today 1999; 5: 225–232
- Esch T, Stefano GB, Fricchione GL, Benson H. Stress-related diseases – a potential role for nitric oxide. Med Sci Monit 2002; 8: 103–118
- Van der Veen RC. Nitric oxide and T-helper cell immunity. Internat Immunopharmacol 2001; 1: 1491–1500
- Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995; 16: 128–130
- Xiao BG, Link H. Immune regulation within the central nervous system. J Neurol Sci 1998; 157: 1–12
- Salvemini D, Seibert K, Masferrer JL, et al. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 1994; 93: 1940–1947
- Trifilieff A, Fujitani Y, Mentz F, Dugas B, Fuentes M, Bertrand C. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 2000; 165: 1526–1533
- Luvara G, Pueo ME, Philippe M, Mandet C, Savoie F, Henrion D, et al. Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: Prevention by angiotension II antagonism. Arteriosclerosis Thrombosis Vasc Path 1998; 18: 1408–1416
- Bocca AL, Hayashi EE, Pinheiro AG, et al. Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response. J Immunol 1998; 161: 3056–3063
- Oseroff A, Okada S, Strober S. Natural suppressor (NS) cells found the the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype. J Immunol 1984; 132: 101–110
- Strober S. Natural killer cells and “natural suppressor” T cells in the bone marrow. J Allergy Clin Immunol 2000; 106: S113–114
- Morrison C, Brummer E, Stevens DA. In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma-interferon results in enhanced fungal killing. Infect Immun 1989; 57: 2953–2958